Vanguard Portfolio Management
ABBV icon

Vanguard Portfolio Management’s AbbVie ABBV Stock Holding History

Vanguard Portfolio Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2B Sell
48,477,996
-1,045,082
-2% -$225M 0.55% 22
2026
Q1 		$10.8B Buy
+49,523,078
New +$11B 0.56% 17

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management's ABBV Position: Q2 2026 in Review

Vanguard Portfolio Management reduced its AbbVie (ABBV) stake by 2.1% in Q2 2026, selling an estimated $225M and leaving 48,477,996 shares worth $12.2B. The position accounts for 0.55% of the portfolio, ranked #22.

Vanguard Portfolio Management first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Vanguard Portfolio Management held 48,477,996 shares of AbbVie worth $12.2B as of Q2 2026.
  • Vanguard Portfolio Management sold 1,045,082 AbbVie shares in Q2 2026, an estimated $225M.
  • AbbVie made up 0.55% of Vanguard Portfolio Management's portfolio in Q2 2026, its #22 holding.
  • Vanguard Portfolio Management first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
  • 4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.